Best Phosphodiesterase 4 Inhibitor for Arthritis, Psoriatic — ranked (2026) · pharmaranks
Best Phosphodiesterase 4 Inhibitor for arthritis, psoriatic
2 Phosphodiesterase 4 Inhibitor drugs indicated for arthritis, psoriatic, ranked by our independent rating. The current highest-rated is otezla. Compare them with all treatments for arthritis, psoriatic or the full Phosphodiesterase 4 Inhibitor class. Not medical advice — always consult a professional.
Rated against independent regulatory sources·Last updated June 25, 2026·How we rate
Top phosphodiesterase 4 inhibitor for arthritis, psoriatic:1. Otezla · 2. Otezla XR
Best-rated Phosphodiesterase 4 Inhibitor for arthritis, psoriatic, ranked by pharmaranks score
What is the best phosphodiesterase 4 inhibitor for arthritis, psoriatic?
By our independent rating, otezla currently ranks highest among Phosphodiesterase 4 Inhibitor drugs used for arthritis, psoriatic. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
Which phosphodiesterase 4 inhibitor drugs treat arthritis, psoriatic?
pharmaranks lists 2 Phosphodiesterase 4 Inhibitor products indicated for arthritis, psoriatic, per FDA drug-label data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.